Clinical Trial Update: Combination Study of Antibiotics With Enzalutamide (PROMIZE) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the PROMIZE study evaluating a combination of antibiotics with enzalutamide in metastatic castration-resistant prostate cancer, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Antibiotics (unspecified) - combination therapy
• Enzalutamide (enzalutamide)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 1, Phase 2 | Status: RECRUITING